Lupin Limited

Lupin Limited is a globally trusted pharmaceutical company founded in 1968, operating a highly diversified manufacturing business across developed and emerging markets. The company maintains a strong regulatory track record with successful inspections and approvals from stringent global regulatory authorities including the US FDA, UK MHRA, and EU GMP.

Quality & Compliance

Quality and compliance are cornerstones of Lupin's operations, guided by the Quality Management Maturity (QMM) model demonstrating a mature, enterprise-wide approach. The company employs:

• Advanced Pharmaceutical Quality Systems with robust, data-driven approaches
• SMART Quality infrastructure including automated PQR, NIR, and bar code-enabled quality control operations
• Electronic Batch Processing Systems, Laboratory Information Management Systems (LIMS), and Electronic Document Management Systems (EDMS)
• Next-generation robotics and integrated ERP platforms
• AI-based solutions for predictive and proactive quality platforms

Manufacturing & Operations

Lupin's manufacturing capabilities span:

• Generics and complex formulations
• Branded products and specialty segments
• Robust R&D and manufacturing infrastructure
• Global presence across 100+ countries

The company is led by 2,000+ quality professionals and a dedicated Corporate Quality Assurance (CQA) organization. Lupin maintains inspection-ready facilities at all times and is committed to manufacturing products of the highest quality from all global manufacturing sites.